Abstract
A case of bone marrow necrosis associated with a serologically documented recent Parvovirus B 19 infection which preceded the development of PH1+ acute lymphoblastic leukemia is reported. No conclusions can be drawn on the basis of a single case but the question of the role of human Parvovirus B19 in the pathogenesis of bone marrow necrosis is discussed. It is suggested that the virus may act as a co-factor for the induction of bone marrow necrosis, in some cases.
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bone Marrow / pathology*
-
Cyclophosphamide / administration & dosage
-
Daunorubicin / administration & dosage
-
Daunorubicin / analogs & derivatives
-
Erythema Infectiosum / complications*
-
Female
-
Humans
-
Karyotyping
-
Methotrexate / administration & dosage
-
Pancytopenia / etiology
-
Parvovirus B19, Human / pathogenicity*
-
Philadelphia Chromosome*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
-
Prognosis
-
Remission Induction
-
Steroids / administration & dosage
-
Vincristine / administration & dosage
Substances
-
Steroids
-
Vincristine
-
Cyclophosphamide
-
Methotrexate
-
Daunorubicin